15 December 2022
Herbert Smith Freehills advises joint sponsors on 3D Medicines' Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为思路迪香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised CICC and CSCI as joint sponsors of 3D Medicines Inc. (01244.HK)’s mainboard listing on the Stock Exchange of Hong Kong.
07 December 2022
New approaches by regulators in effort to protect consumers from frauds, failures and fads
A new report suggests regulators across the globe are changing their focus, moving from an emphasis on 'aggressive enforcement' towards a more proactive approach designed to foster market stability, build operational resilience and protect vulnerable consumers.
18 November 2022
Herbert Smith Freehills and Hiswara Bunjamin & Tandjung advise Silk Road Fund on investment in Indonesian pharmaceutical SOEs 史密夫斐尔及Hiswara Bunjamin & Tandjung为丝路基金投资印尼国有制药企业提供法律咨询
Leading international law firm Herbert Smith Freehills and its associate firm Hiswara Bunjamin & Tandjung have advised China's Silk Road Fund on a strategic partnership with PT Kimia Farma Tbk, jointly with Indonesia Investment Authority (INA). 国际领先的律师事务所史密夫斐尔和印尼联营所Hiswara Bunjamin &...
16 November 2022
Helen Tang elected as Vice-Chair of ICC's Commission on Arbitration and ADR 唐汉洁律师当选国际商会(ICC)仲裁及ADR委员会副主席
Herbert Smith Freehills partner Helen Tang has been elected as one of eight new Vice-Chairs of the ICC's Commission on Arbitration and ADR. 史密夫斐尔律师事务所合伙人唐汉洁(Helen Tang)律师被国际商会仲裁及替代性争议解决(ADR)委员会(The ICC Commission on Arbitration and ADR)任命为新一届八位副主席之一。
11 November 2022
Herbert Smith Freehills renews China leadership to strengthen business 史密夫斐尔焕新中国管理层 加强中国业务
Leading international law firm Herbert Smith Freehills has appointed partner Nanda Lau to lead the firm's Beijing and Shanghai representative offices, as part of its expansion plans for China and Asia. 领先的国际律师事务所史密夫斐尔任命合伙人刘依兰(Nanda Lau)律师领导北京和上海代表处，这是本所扩展中国市场和亚洲地区业务的最新举措。
08 November 2022
Herbert Smith Freehills advises CICC as the sole sponsor on LEPU ScienTech's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人中金公司律师为乐普心泰医疗香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (02291.HK)'s listing on the Main Board of the Hong Kong Stock Exchange.
01 November 2022
Leading for Impact: Herbert Smith Freehills publishes sixth annual responsible business report
Herbert Smith Freehills has today published its sixth annual Responsible Business Report. Highlighting the actions taken by our firm to engage with, and address, the challenges and opportunities faced by our clients and the communities in which we operate, the report demonstrates our ongoing...
20 October 2022
Internet generation ensures banks clock the need for change to meet expectations of customers and staff
Broadening their appeal to a new generation of customers and reacting to the shifting demands of today's bankers are key concerns for the global banking industry, according to a new report from Herbert Smith Freehills.
10 October 2022
Herbert Smith Freehills advises sponsors on Jenscare's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为健世科技香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation and Citigroup as joint sponsors of Jenscare Scientific Co., Ltd. (09877.HK)'s listing on the Main Board of the Hong Kong Stock Exchange.
29 September 2022
Herbert Smith Freehills advises sponsors on Onewo Inc's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为万物云香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised CITIC Securities, Citigroup and Goldman Sachs as joint sponsors of Onewo Inc. (02602.HK)'s listing on the Main Board of the Hong Kong Stock Exchange.
01 September 2022
Herbert Smith Freehills advises sponsors on Biocytogen Pharmaceuticals' Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为百奥赛图香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (02315.HK)'s listing on the Main Board of the Hong Kong Stock Exchange.
Loading Results
Loading